ISSN 2149-2263 | E-ISSN 2149-2271
The Anatolian Journal of Cardiology
Renin-angiotensin system blockade in the treatment of heart failure and the role of valsartan in this treatment [Anatol J Cardiol]
Anatol J Cardiol. 2014; 14(Suppl 2): 1-8 | DOI: 10.5152/akd.2014.00001

Renin-angiotensin system blockade in the treatment of heart failure and the role of valsartan in this treatment

Burçak Kılıçkıran Avcı1, Barış İkitimur1, Bilgehan Karadağ1, Zeki Öngen1
Department of Cardiology, Cerrahpaşa Faculty of Medicine, İstanbul University; İstanbul-Turkey

Heart failure which occurs due to various causes including primarily coronary artery diseases and hypertension is a syndrome with complex physiopathology and clinic that can impair patients’ quality of life or lead to death. However, it is well known that the activation of renin-angiotensin system (RAS) has an important role in the physiopathology of heart failure with reduced ejection fraction. Therefore, suppression of this system for achieving a gain in the treatment of the disease has been among prominent concerns. In this review, the place of RAS suppressive drugs and valsartan, which is an angiotensin receptor blocker, in heart failure will be examined.

Keywords: heart failure, angiotensin receptor blockers, valsartan

Burçak Kılıçkıran Avcı, Barış İkitimur, Bilgehan Karadağ, Zeki Öngen. Renin-angiotensin system blockade in the treatment of heart failure and the role of valsartan in this treatment. Anatol J Cardiol. 2014; 14(Suppl 2): 1-8
Manuscript Language: English


Journal Metrics

Journal Citation Indicator: 0.18
CiteScore: 1.1
Source Normalized Impact
per Paper:
0.22
SCImago Journal Rank: 0.348

Quick Search



Copyright © 2024 The Anatolian Journal of Cardiology



Kare Publishing is a subsidiary of Kare Media.